Skip to content
The Nexus
DossierENTITY

balance sheets

Coverage of balance sheets in the Nexus archive.

Earliest in view: Apr 27 · 15:23 UTCMost recent: Aug 3 · 16:33 UTC
Co-mentioned in this coverage
AstraZenecaorganization1Bristol-Myers Squibborganization1Blockbuster drugstopic1Gate CrossExorganization1institutional capital fragmentationtopic1CEXstopic1collateraltopic1Bitcointopic1institutional investorstopic1store of valuetopic1diversificationtopic1TheresNoSecondBestperson1
Recent coverage
  • BUSINESSAug 3 · 16:33 UTCFINANCIAL TIMES WORLD
    AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough

    AstraZeneca and Bristol-Myers Squibb suggest that larger financial resources enable greater investment in potential blockbuster drugs. The article highlights the advantage of enlarged balance sheets in pharmaceutical development.

  • BUSINESSJun 16 · 13:24 UTCTHE BLOCK
    Gate CrossEx: An Exchange-Native Answer to the Institutional Capital Fragmentation Problem

    Gate CrossEx is presented as an exchange-native solution to the problem of institutional capital fragmentation in crypto markets. The article highlights that sophisticated crypto desks face challenges in moving capital quickly across separate balance sheets on centralized exchanges (CEXs), as collateral cannot be netted across venues.

  • BUSINESSApr 27 · 15:23 UTCR/BITCOIN
    Why More Institutional Investors Are Adding Bitcoin to Their Balance Sheets

    The article discusses the increasing trend of institutional investors incorporating Bitcoin into their balance sheets, driven by its adoption as a store of value and diversification strategy. Key factors include growing institutional confidence and Bitcoin's role in modern portfolio management.